In Vitro Diagnostics Business Outlook: Volume 1, Issue 19 - Molecular Inherited Disease Testing

A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:

• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
Table of Contents
  • Untitled Chapter
  • Market Analysis:
    • Overview of Molecular Inherited Disease Testing
    • Market Outlook
      • Major Product Activity
    • Company Briefs
      • Myriad Genetic
      • PerkinElmer
    • Regional Market
  • Executive News Briefing
    • Beckton Dickinson Appoints New Supply Chain Officer
    • Meridian Bioscience Agrees to be Acquired
  • Financial Highlights: Agilent, Fulgent Genetics, Mainz Biomed
    • Agilent Q2 ‘22 Growth up 5%; 7% on Core Basis
    • Fulgent Genetics Posts Strong Performance in Core Revenue
    • Mainz Biomed Reports Strong Sales for ColoAlert - Boosting Company Performance
  • Diagnostic Market Mergers, Acquisitions and Partnership Deals
    • Partnerships and Collaborations
    • Mergers and Acquisitions
  • Industry Watch
    • COVID-19 Update
    • Australia
  • Broad-based Company Announcements
    • Thermo Fisher Launches New Molecular Respiratory Panel
    • Bio-Techne Launches RNAscope ISH Probe
    • Accelerate Diagnostics Gains CE Mark
    • Mylab Discovery Solutions Launches Combined RT-PCR Test Kit
Attachments
  • IVDBO - Vol 1. Issue 19.pdf